Drug Type Synthetic peptide |
Synonyms NX 001, NX001 |
Target |
Action modulators |
Mechanism Growth factor receptor modulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC66H91N19O23 |
InChIKeyRQGZXHACOJLCHT-SJVKHLBFSA-N |
CAS Registry225932-91-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Delayed Graft Function | Phase 1 | United States | - |